Multi-Institutional Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of Manual Maintenance Therapy for Chronic Bothersome Neck Pain

一项多中心实用性随机对照试验,旨在评估手法维持疗法对慢性颈痛的疗效

阅读:1

Abstract

PURPOSE: Numerous studies have analyzed the effects of Chuna therapy, a manual therapy technique used in Korea, on musculoskeletal disorders. However, research on Chuna maintenance therapy (CMT), which aims to prevent the recurrence of disorders and improve health status through regular long-term application, is lacking. This protocol outlines a randomized clinical trial designed to evaluate the comparative effectiveness of CMT for chronic neck pain, particularly in cases where mild discomfort has become habitual. PATIENTS AND METHODS: This two-arm, multi-institutional, assessor-blinded, pragmatic randomized controlled trial will enroll 250 participants with chronic bothersome neck pain for more than 12 months and an average Numeric Rating Scale (NRS) score of 2-4 over the past month, recruited from seven Korean medicine hospitals. Participants will be randomly assigned to one of two groups: the CMT group or the self-care and exercise (SE) group. Over a total period of 20 weeks, the CMT group will receive 10 treatment sessions, while the SE group will receive 5 education sessions. After treatment completion, a follow-up will be conducted twice over a 6-week period. The primary outcome are the average neck pain NRS score and the Neck Disability Index (NDI), both assessed over the preceding 2 weeks. Secondary outcomes include the Visual Analog Scale, number of days with bothersome neck pain, recurrence, the Patient Global Impression of Change, Credibility and Expectancy Questionnaire, quality of life, cost-effectiveness evaluation, and safety assessments. For the primary analysis, group-specific areas under the curve for NRS and NDI will be calculated using a linear mixed model. The primary endpoint is the first follow-up visit (Visit 11) after treatment completion. CONCLUSION: The findings may inform clinical and policy decision-making by providing evidence on the effectiveness, safety, and cost-effectiveness of CMT. TRIAL REGISTRATION NUMBER: This study is registered at ClinicalTrials.gov (NCT06591221; September 7, 2024) and the Clinical Research Information Service (CRIS; KCT0009798).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。